Advertisement

Topics

Celyad licenses CAR-T patents to Novartis

15:40 EDT 4 May 2017 | Elsevier Business Intelligence

Celyad SA licensed Novartis AG nonexclusive rights to its patents related to the production of allogeneic CAR-T cells.

Original Article: Celyad licenses CAR-T patents to Novartis

NEXT ARTICLE

More From BioPortfolio on "Celyad licenses CAR-T patents to Novartis"

Quick Search
Advertisement
 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...